Rare and massive odontogenic parakeratotic cyst treated by endoscopic sinus surgery: a case report by Dario Marcotullio et al.
JOURNAL OF MEDICAL
CASE REPORTS
Marcotullio et al. Journal of Medical Case Reports 2014, 8:293
http://www.jmedicalcasereports.com/content/8/1/293CASE REPORT Open AccessRare and massive odontogenic parakeratotic cyst
treated by endoscopic sinus surgery: a case
report
Dario Marcotullio1, Giannicola Iannella1, Melissa Zelli2, Caterina Marinelli1 and Giuseppe Magliulo1*Abstract
Introduction: Keratocystic odontogenic tumors are benign neoplasms of odontogenic origin with a potential for
aggressive and infiltrative behavior. Many different treatments for this type of lesion have been reported. However,
no common consensus has emerged to date regarding the most effective therapeutic approach. Cases of maxillary
sinus giant keratocystic odontogenic tumors completely excised by enucleation or marsupialization via endoscopic
sinus surgery are extremely rare, and, to the best of our knowledge, only one case has been described in the
literature since 2005.
Case presentation: We report a case of a 24-year-old Italian man who came to our department with maxillary sinus
region swelling, pain and left nasal obstruction. A massive keratocystic odontogenic tumor involving the right
maxillary sinus and causing focal erosions of the bony walls was diagnosed. The keratocystic odontogenic tumor
was removed as much as possible by a transnasal approach using endoscopic sinus surgery, which produced
optimal surgical and prognostic outcomes. Follow-up is reported for an 8-year period.
Conclusion: Conservative management in this case demonstrated good therapeutic efficacy with a low risk of
recurrence. For injuries involving the maxillary sinus, the possibility of decompression or marsupialization by
endoscopic sinus surgery should always be considered because it demonstrated the potential to lead to excellent
results even after 8 years of follow-up in our patient. To our knowledge, no case report has described follow-up
longer than 8 years for a maxillary sinus keratocystic odontogenic tumor treated with endoscopic sinus surgery.
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Keratocystic odontogenic tumors are benign neoplasms of
odontogenic origin with a potential for aggressive and in-
filtrative behavior [1-3]. The odontogenic keratocyst was
described for the first time by Philipsen [4] in 1956. In
2005, the World Health Organization (WHO) re-classified
odontogenic neoformations, replacing the old definition of
odontogenic keratocyst (OKC) with a new one, designated
keratocystic odontogenic tumor (KCOT) [5,6]. The new
classification is justified by the well-known features of this
lesion in terms of growth, histological features and know-
ledge of underlying genetic mechanisms that may explain
its development [2,5,7].* Correspondence: giuseppemagliuloorl@yahoo.com
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article, unless otherwise stated.Many different treatments for this type of lesion, ranging
from simple curettage to highly invasive en bloc resection,
have been reported. However, no common consensus
regarding the most effective therapeutic approach has
emerged to date [1,2].
Although several cases of odontogenic parakeratotic
cysts have been reported in the literature, only a few were
related to the new WHO classification [1,3]. In addition,
among these cases, maxillary sinus giant KCOTs com-
pletely excised by enucleation or marsupialization via
endoscopic sinus surgery (ESS) have been extremely rare,
and, to the best of our knowledge, only one case has been
described in the literature since 2005 [3].
In this case report, we present our experience in treat-
ing a patient with a KCOT removed by means of an ESS
approach. There was no recurrence during 8 years of
follow-up.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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A 24-year-old Italian man came to our department com-
plaining of a 3-month history of left maxillary sinus region
swelling with left nasal obstruction and associated mild fa-
cial pain. He had a history of repeated cycles of antibiotic
therapy without any symptomatic improvement.
At the clinical examination, tumefaction was found to
involve the body and ascending ramus of the maxillary
sinus with intact overlying skin. No epistaxis, peri-orbital
proptosis, cranial nerve palsies or paresthesias were evi-
dent. Fiber-optic rhinoscopy showed that the middle nasal
meatus was partially occupied by a reddish mass that was
not bleeding, together with strongly hyperemic surround-
ing mucosa. Erosion of the medial walls of the maxillary
sinus could be seen. The right nasal cavity was apparently
normal.
A computed tomography (CT) scan of the paranasal
sinuses showed irregularly dense solid tissue that entirely
occupied the right maxillary sinus, with massive erosion
of the anterior and posterior walls of the sinus. Infer-
iorly, the mass encased the dental roots of the corre-
sponding right dental arch, and its extension into the
nasal cavity created induced compression and deflection
of the nasal septum. No enhancement after contrast ad-
ministration was evident (Figure 1).
To remove the mass, ESS was performed. After surgi-
cal volume reduction using radiofrequency of the infer-
ior turbinate, the maxillary ostium was enlarged and the
cystic lesion was opened and decompressed. Marsupiali-
zation was performed, and the cystic wall was also re-
moved as much as possible.Figure 1 Pre-operative computed tomography scan. Image
shows a solid neoformation occupying the right maxillary sinus,
erosion of the anterior and posterior walls of the sinus and mass
extension to the corresponding right dental roots and the nasal
cavity, with compression and deflection of the nasal septum. There
was no enhancement after contrast administration.The histological examination revealed the presence of
a cyst wall characterized by a few cell layers of squamous
parakeratotic epithelium. In some areas, the epithelium
was dehiscent with granulation tissue. Lymphocytes and
plasma cells could be seen (Figure 2). Such histological
features were compatible with the diagnosis of KCOT.
The post-operative evaluation revealed no recurrence of
the disease, with steady improvement in the patient’s clin-
ical condition. Owing to the high tendency of KCOTs to
recur, we opted for a long radiological follow-up with CT
performed annually for the first 5 years and every 3 years
thereafter.
At the patient’s 8-year follow-up examination, a post-
operative CT scan showed no KCOT recurrence in the
right maxillary sinus. Scarce pathologic tissue could be
seen in the alveolar recess of the right maxillary sinus
(Figure 3).
Discussion
In 2005, the new histological classification of odonto-
genic tumors was introduced by the WHO, which re-
classified the OKC as a benign intra-osseous neoplasia,
the so-called keratocystic odontogenic tumor [5,6]. Ori-
ginating from the dental blade or its residue, this tumor
represents 2% to 11% of all mandibular cysts [7]. Occur-
ring at any age, these tumors primarily affect men, at an
approximate ratio of 2:1 [8]. They are more often located
in the mandible than in the maxilla, where they are far
less frequently found [1,8]. Simiyu et al. [8] reported a
total of 22 confirmed cases of KCOT, among which 15
(68.2%) occurred in the mandible, 6 (27.3%) occurred in
the maxilla and 1 (4.5%) was in both jaws and was asso-
ciated with Gorline-Goltz syndrome.
With regard to symptoms, several researchers have re-
ported that 50% to 90% of KCOTs are symptomatic at
the time of diagnosis [1]. The chief presenting symptom
appears to be swelling in combination with pain, pus
discharge and nasal obstruction [1,9].
KCOT is characterized by very aggressive local behav-
ior with a high rate of recurrence, ranging from 3% to
60% [1,8-10]. It should be noted that, because of their
expansive potential, KCOTs may easily reach an enor-
mous size and occupy the entire maxilla or the nasal
fossa [1,3]. Sinus infection and signs of bone erosion
may also be observed. Extra-osseous occurrence of a
KCOT is exceedingly rare [1,3].
KCOTs may appear as small, round or ovoid, multi-
lobulated lesions with well-defined margins and a radio-
lucent appearance on CT scans [1]. Signs of bone erosion
can often be seen [3]. A characteristic regular, parakerati-
nized, stratified squamous epithelium and a well-defined
basal layer of columnar or cuboidal cells are among the
important histological features distinguishing KCOTs
from other jaw cysts [1,10]. The epithelial lining may
Figure 2 Histological study of the patient’s keratocystic odontogenic tumor. Image shows cell layers of squamous parakeratotic epithelium
and areas of dehiscent epithelium with granulation tissue.
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potential for malignant transformation into squamous cell
carcinoma, though rare, has been reported [7,8,11].
In a series of 32 surgically treated KCOTs, Kuroyanagi
et al. [7] observed significant expression of Ki-67 and
p53 in the group with recurrences, suggesting that the
evaluation of these marker proteins could help in the as-
sessment of prognostic risks for malignant transform-
ation and the need for eventual adjuvant treatment.
KCOT recurrence rates vary enormously, from a max-
imum of 62% to a minimum of 0% [9-11]. Recurrence
may not be a consequence of the type of surgical manage-
ment, but rather a reflection of the nature of the lesion it-
self [2,12]. Woolgar et al. [11] explained that similar
recurrence risk could be attributable to incomplete re-
moval of the original cyst lining or of a new KCOTgrowthFigure 3 Post-operative computed tomography scan taken at
the 8-year follow-up examination. Scan shows no keratocystic
odontogenic tumor recurrence to the right maxillary sinus and scarce
pathologic tissue in the alveolar recess of the right maxillary sinus.from small satellite cysts, or to an odontogenic epithelial
residue left during surgical treatment. Moreover, the de-
velopment of an unrelated KCOT in an adjacent bone re-
gion is often interpreted as a recurrence.
The appropriate treatment of KCOT lesions is still de-
batable [1-3]. Most surgeons advocate complete removal
of the lesion with extension margins or meticulous cur-
ettage of the surrounding tissues as the best type of
treatment [1,10]. Unfortunately, enucleation alone is as-
sociated with the highest recurrence rates (range, 17% to
56%), particularly when the cyst is removed in a piece-
meal fashion [3,9]. To decrease the recurrence risk, vari-
ous adjunctive therapies have been attempted, including
peripheral ostectomy and the use of Carnoy’s solution,
cryotherapy or electrocautery [1,3,10].
Recently, the surgical risk, morbidity and relatively
high rate of recurrence even after the use of aggressive
surgical techniques have resulted in increased use of
conservative treatment [1-3,9,12]. Decompression and
marsupialization are valid conservative options in the
treatment of KCOTs [1-3,9]. Marsupialization was first
described by Partsch [13,14] in 1882 for the treatment
of cystic lesions. This technique is based on the
externalization of the cyst through the creation of a
surgical window in the buccal mucosa and the cystic
wall. The borders are then sutured to create an open
cavity that communicates with the oral cavity. This pro-
cedure relieves pressure created by the cystic fluid,
allowing reduction of the cystic space and facilitating
bone apposition to the cystic walls [1,13-15].
Pogrel et al. [15] described 10 patients with KCOTs
treated by marsupialization in whom the pathology re-
solved completely, both clinically and radiographically.
It should be noted that if KCOTs exist in the maxilla,
which is adjacent to the nasal cavity, the ESS via the
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marsupialization [3]. Ohki et al. [3] are the only authors
to date, to the best of our knowledge, to report transna-
sal marsupialization using an ESS technique to remove
the cystic wall and enlarge the maxillary ostium. They
achieved excellent results with this procedure. We used
the same surgical technique in our patient, who was
KCOT recurrence-free at his 8-year follow-up examin-
ation. To our knowledge, no case report has described
follow-up longer than 8 years for a maxillary sinus
KCOT treated with ESS, confirming that conservative
treatment may be an optimal alternative. Larger series
with an adequate long-term follow-up period are re-
quired to definitively clarify the clinical validity of ESS
for preventing recurrence [2].
Conclusion
Our case report confirms the data reported in the litera-
ture to date regarding the clinical and histological features
of odontogenic parakeratotic cysts. Our conservative man-
agement of our patient demonstrated good therapeutic ef-
ficacy with a low risk of recurrence. For injuries involving
the maxillary sinus, the possibility of decompression or
marsupialization by ESS should always be considered and
has the potential to produce excellent results even after
several years of follow-up.
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